LEAVITT PARTNERS, LLC

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $20,000.00 income · posted Jul 15, 2026

Bills named in this filing 2

Lobbying activity 1

Health Issues

Newborn screening and pharmaceuticals. The Accelerating Kids Access to Care Act (H.R. 1509/S. 752).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.